Test Price
2,800 AED✅ Home Collection Available
SLC20A2 Gene Idiopathic Basal Ganglia Calcification Type 1 – Genetic Test in UAE
Executive Summary & Core Metrics
The SLC20A2 gene sequencing test uses next-generation sequencing (NGS) to detect pathogenic variants associated with idiopathic basal ganglia calcification type 1 (Fahr's disease). This focused analysis provides high-resolution clinical diagnosis, carrier screening, and family risk assessment. The service includes certified genetic counselling, secure sample logistics, and telephonic result guidance, all delivered under UAE regulatory standards.
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Processing.
- ✓Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- ✓Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with genetic counsellors.
- ✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SLC20A2 NGS test targets 100% of coding exons and flanking intronic regions of the SLC20A2 gene. This focused sequencing approach identifies single nucleotide variants (SNVs), small insertions and deletions (indels), and copy number variants (CNVs) with greater than 99.9% analytical sensitivity. The test is indicated for individuals presenting with progressive neurological symptoms, bilateral basal ganglia calcifications on neuroimaging, or a family history of Fahr's disease. Results are interpreted in the context of clinical findings and integrated with genetic counselling to guide personalised management.
| Feature | Our NGS Test (SLC20A2 Full Gene) | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Target Coverage | 100% of coding exons & flanking intronic regions | Broad coverage; may miss SLC20A2 if not prioritised |
| Analytical Sensitivity | >99.9% for SNVs, indels, CNVs | Variable, typically 95–98% |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Clinical Report | Focused interpretation with integrated genetic counselling | Requires additional bioinformatics filtering |
| Price in UAE | 2,800 AED | 4,000–5,500 AED |
Physician Insight & Safety Protocols
"Genetic analysis of SLC20A2 provides a definitive molecular diagnosis for idiopathic basal ganglia calcification type 1, but results must always be correlated with clinical presentation and neuroimaging findings. I advise patients to document a detailed three-generation family history to enhance variant interpretation. Early molecular confirmation enables tailored surveillance and timely referral to neurology and genetic counselling services. Partner with your treating physician to translate genetic findings into a meaningful care plan." — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Advisory
Do not discontinue or alter any prescribed medication without consulting your treating physician. This genetic test provides diagnostic information and does not replace ongoing neurological management or emergency care.
Safety Exclusion Criteria & Emergency Red Flags
- Not for acute medical emergencies; this test requires 3–4 weeks for results.
- Patients under 18 years must have parental or guardian consent in accordance with UAE Federal Law No. 2 of 2019.
- If you experience sudden severe headaches, confusion, seizures, or involuntary movements, seek immediate emergency medical attention.
- Do not delay essential neurological care while awaiting genetic results.
Patient FAQ & Clinical Guidance
1. What does the SLC20A2 genetic test diagnose?
This test identifies pathogenic variants in the SLC20A2 gene that cause idiopathic basal ganglia calcification type 1, also known as Fahr's disease. The condition is characterised by progressive calcium deposition in the basal ganglia, leading to neurological symptoms such as movement disorders, cognitive decline, and psychiatric disturbances. Early genetic diagnosis supports personalised monitoring and family risk assessment.
2. How is the sample collected and what is the turnaround time?
We accept peripheral whole blood, extracted DNA, or a dried blood spot on an FTA card. Results are delivered within 3–4 weeks via a secure online portal. The laboratory uses ISO 9001:2015 certified NGS workflows to ensure accuracy and traceability throughout the testing process.
3. Is home sample collection available in the UAE?
Yes, our VIP Mobile Phlebotomy service provides hospital-grade home collection across Dubai, Abu Dhabi, and all Emirates, available daily from 8 AM to 11 PM. Samples are transported under temperature-controlled cold-chain conditions to maintain integrity. This service is ideal for patients with mobility concerns or busy schedules.
4. Will my genetic data remain private and protected?
Absolutely. All genetic information is handled in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of ICT in Health Fields. Results are shared only with you and your designated physician unless explicit consent is provided for additional use.
5. Do I need a doctor's referral to proceed with this test?
A referral from a neurologist or primary care physician is recommended to ensure clinical appropriateness and to facilitate result interpretation. Our genetic counsellors can assist in coordinating with your healthcare provider. Direct patient inquiries are welcome for initial consultation.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All laboratory processes are certified under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Genetic counselling and patient consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability to ensure safety and informed decision-making.
Clinical & Logistical Metadata
| Test Name | SLC20A2 Gene Sequencing – Idiopathic Basal Ganglia Calcification Type 1 (Fahr's Disease) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Coding Exons & Flanking Intronic Regions |
| ICD-10-CM Code | G23.8 |
| LOINC Code | 101376-5 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians